Top

Neurological Sciences

Published in:

01-01-2020 | Amyotrophic Lateral Sclerosis | Letter to the Editor

Elevated CSF neurofilament light chain concentration in a patient with facial onset sensory and motor neuronopathy

Authors: Kristin S. Lange, André Maier, Christoph Leithner

Published in: Neurological Sciences | Issue 1/2020

Excerpt

Dear Editor, …

Zheng Q, Chu L, Tan L, Zhang H (2016) Facial onset sensory and motor neuronopathy. Neurol Sci 37:1905–1909CrossRef

Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, Petzold A, Blennow K, Zetterberg H, Kuhle J (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14(10):577–589CrossRef

Yilmaz A, Blennow K, Hagberg L, Nilsson S, Price RW, Schouten J, Spudich S, Underwood J, Zetterberg H, Gisslén M (2017) Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Expert Rev Mol Diagn 17(8):761–770CrossRef

Ziso B, Williams TL, Walters RJL, Jaiser SR, Attems J, Wieshmann UC, Larner AJ, Jacob A (2015) Facial onset sensory and motor neuronopathy: further evidence for a TDP-43 proteinopathy. Case Rep Neurol 7:95–100CrossRef

Vucic S, Stein TD, Hedley-Whyte ET, Reddel SR, Tisch S, Kotschet K, Cros D, Kiernan M (2012) FOSMN syndrome: novel insight into disease pathophysiology. Neurology 3:73–79CrossRef

Dalla Bella E, Rigamonti A, Mantero V, Morbin M, Saccucci S, Gellera C, Mora G, Lauria G (2014) Heterozygous D90A-SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: a bridge to amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 85:1009–1011CrossRef

Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A (2015) Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84(22):2247–2257CrossRef

Hu X, Yang Y, Gong D (2017) Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson’s disease: a meta-analysis. Neurol Sci 38(3):407–414CrossRef

Osborn KE, Liu D, Samuels LR, Moore EE, Cambronero FE, Acosta LMY, Bell SP, Babicz MA, Gordon EA, Pechman KR, Davis LT, Gifford KA, Hohman TJ, Blennow K, Zetterberg H, Jefferson AL (2018) Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities. Neurobiol Aging 68:18–25CrossRef

Title: Elevated CSF neurofilament light chain concentration in a patient with facial onset sensory and motor neuronopathy
Authors: Kristin S. Lange
André Maier
Christoph Leithner
Publication date: 01-01-2020
Publisher: Springer International Publishing
Keywords: Amyotrophic Lateral Sclerosis
Dysarthria
Published in: Neurological Sciences / Issue 1/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-04033-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Elevated CSF neurofilament light chain concentration in a patient with facial onset sensory and motor neuronopathy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Low homoarginine/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies

Neural correlates of different behavioral response to transcranial direct current stimulation between patients in the unresponsive wakefulness syndrome and minimally conscious state

High HbA1c level is correlated with blood-brain barrier disruption in syphilis patients

Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia—an observational study

Correction to: Aging with multiple sclerosis: prevalence and profile of cognitive impairment

Hesperidin reduces adverse symptomatic intracerebral hemorrhage by promoting TGF-β1 for treating ischemic stroke using tissue plasminogen activator